NCT00671112 2015-10-28Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaCase Comprehensive Cancer CenterPhase 1 Terminated30 enrolled
NCT00901147 2014-06-27Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell LymphomaSingapore General HospitalPhase 2 Completed25 enrolled
NCT00810576 2012-08-07Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's LymphomaM.D. Anderson Cancer CenterPhase 2 Terminated1 enrolled 3 charts